Magenta Therapeutics Inc. (MGTA)
NASDAQ: MGTA
· Real-Time Price · USD
0.70
-0.06 (-7.69%)
At close: Sep 11, 2023, 10:00 PM
Magenta Therapeutics Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | 7.4M | 6.24M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost of Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Income | -167.89M | -150.47M | -75.24M | -41.46M | -40.99M | -42.48M | -53.19M | -80.9M | -79.31M | -80.3M | -79.83M | -74.69M | -73.62M | -73.75M | -76.16M |
Interest Income | 22.23M | 19.47M | 14.27M | 12.79M | 8.08M | 8.24M | 4.96M | 2.89M | 3.73M | 3.36M | 2.55M | 2.87M | 2.92M | 2.81M | 3.74M |
Pretax Income | -110.04M | -95.3M | -60.83M | -64.82M | -67.39M | -68.69M | -82.68M | -76.46M | -75.58M | -76.94M | -76.6M | -71.14M | -70.01M | -70.26M | -72.41M |
Net Income | -113M | -98.26M | -60.83M | -61.86M | -67.32M | -69.81M | -83.8M | -80.54M | -76.77M | -76.94M | -76.6M | -71.14M | -70.01M | -70.26M | -72.41M |
Selling & General & Admin | 24.68M | 26.07M | 26.57M | 26.17M | 26.11M | 23.44M | 24.61M | 25.76M | 26.84M | 28.24M | 28.24M | 27.93M | 27.71M | 26.85M | 27.77M |
Research & Development | 137.63M | 118.58M | 51.71M | 34.16M | 31.88M | 35.13M | 46.59M | 55.14M | 52.47M | 52.06M | 51.59M | 46.77M | 45.91M | 46.9M | 48.38M |
Other Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Expenses | 162.31M | 144.65M | 78.28M | 60.33M | 58M | 58.57M | 71.19M | 80.9M | 79.31M | 80.3M | 79.83M | 74.69M | 73.62M | 73.75M | 76.16M |
Interest Expense | n/a | n/a | n/a | n/a | n/a | 1.19M | 1.19M | 1.19M | 1.19M | n/a | n/a | n/a | n/a | n/a | n/a |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 71.83M | 88.52M | 22.14M | 36.27M | 58M | 58.57M | 71.19M | 80.9M | 79.31M | 80.3M | 79.83M | 74.69M | 73.62M | 73.75M | 76.16M |
Income Tax Expense | 8.97M | 8.97M | n/a | -2.96M | -74K | 1.12M | 1.12M | 4.08M | 1.19M | n/a | n/a | n/a | n/a | n/a | n/a |
Shares Outstanding (Basic) | 3.91M | 3.91M | 3.91M | 3.91M | 3.91M | 3.19M | 3.19M | 3.12M | 3.12M | 58.82M | 58.8M | 58.79M | 58.58M | 53.71M | 48.57M |
Shares Outstanding (Diluted) | 3.91M | 3.91M | 3.91M | 3.91M | 3.91M | 3.19M | 3.19M | 3.12M | 3.12M | 58.82M | 58.8M | 58.79M | 58.58M | 53.71M | 48.57M |
EPS (Basic) | -5.48 | -1.71 | -15.76 | -17.53 | -20.4 | -22.15 | -21.41 | -13.59 | -6.54 | -1.31 | -1.34 | -1.31 | -1.36 | -1.43 | -1.59 |
EPS (Diluted) | -5.48 | -1.71 | -15.76 | -17.53 | -20.4 | -22.15 | -21.41 | -13.59 | -6.54 | -1.31 | -1.34 | -1.31 | -1.36 | -1.43 | -1.59 |
EBITDA | -121.24M | -103.82M | -71.4M | -37.2M | -36.27M | -37.29M | -51.83M | -78.75M | -77.63M | -78.56M | -77.61M | -73.21M | -72.13M | -72.31M | -74.69M |
EBIT | n/a | -15.76M | -23.13M | -19.26M | -42.32M | -41.44M | -34.06M | -61.77M | -38.71M | -42.08M | -59.69M | -54.55M | -54.55M | -54.69M | -57.09M |
Depreciation & Amortization | -4.22M | -4.26M | 3.8M | 4.22M | 4.68M | 5.19M | 1.14M | 1.93M | 1.99M | 2.06M | 2.76M | 2.02M | 1.98M | 1.94M | 1.96M |